INTERVIEWS (Under Construction) October 8, 2016 0 Peter Leonardi, PhD, CEO of OmniCyte OmniCyte Founder, Peter Leonardi, provides insight into the emerging field of immunotherapy. Immunotherapy is the…
Uncategorized December 19, 2011 0 Excelimmune Optimizes the Natural Power of the Immune System MRSA, which is commonly acquired through contact within the community, is resistant to most first-line antimicrobials on the market.